• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际儿童咨询网络:儿科临床研究中患者参与的多方面方法。

International Children's Advisory Network: A Multifaceted Approach to Patient Engagement in Pediatric Clinical Research.

作者信息

Gwara Meghan, Smith Sharon, Woods Christine, Sheeren Elizabeth, Woods Hampton

机构信息

International Children's Advisory Network, Hartford, Connecticut.

International Children's Advisory Network, Hartford, Connecticut; Connecticut Children's Medical Center, Hartford, Connecticut.

出版信息

Clin Ther. 2017 Oct;39(10):1933-1938. doi: 10.1016/j.clinthera.2017.09.002. Epub 2017 Sep 22.

DOI:10.1016/j.clinthera.2017.09.002
PMID:28943115
Abstract

Pediatric youth advisory groups were created to provide insight and guidance to the clinical research community. Such efforts have become a priority and parallel the demand for patient-centered health care. While steps are being made to integrate the patient voice into research, there remains a lack of pediatric-specific engagement in the development of pharmaceuticals and in clinical research. For example, a significant number of children are still treated with medications that are not approved for use in this age group, due to a lack of clinical trials involving younger children and neonates. The American Academy of Pediatrics noted that physicians are faced with an ethical dilemma, as they must frequently either not treat children with potentially beneficial medications or treat them with medications based on adult studies or anecdotal empirical experience in children. By improving the approach to pediatric study design, indications for pediatric-specific therapies can be developed. We describe a structured organization with empowered youth and parents who are beginning to play a key role in the research process that suggests ways to improve pediatric research and for innovative medical products to be more "child friendly" and usable. We will also describe how investigators can engage the International Children's Advisory Network to obtain valuable youth perspectives on many aspects of clinical research and health care advocacy.

摘要

儿科青年咨询小组的设立旨在为临床研究界提供见解和指导。此类举措已成为优先事项,与以患者为中心的医疗保健需求并行。虽然正在采取措施将患者的声音纳入研究,但在药品研发和临床研究中仍缺乏针对儿科的参与。例如,由于缺乏涉及年幼儿童和新生儿的临床试验,大量儿童仍在使用未被批准用于该年龄组的药物进行治疗。美国儿科学会指出,医生面临着伦理困境,因为他们常常要么不给儿童使用可能有益的药物,要么根据成人研究或儿童的轶事经验用药。通过改进儿科研究设计方法,可以开发出儿科特定疗法的适应症。我们描述了一个由赋权的青年和家长组成的结构化组织,他们开始在研究过程中发挥关键作用,提出改进儿科研究的方法,使创新医疗产品更“儿童友好”且可用。我们还将描述研究人员如何与国际儿童咨询网络合作,以获取关于临床研究和医疗保健倡导诸多方面的宝贵青年观点。

相似文献

1
International Children's Advisory Network: A Multifaceted Approach to Patient Engagement in Pediatric Clinical Research.国际儿童咨询网络:儿科临床研究中患者参与的多方面方法。
Clin Ther. 2017 Oct;39(10):1933-1938. doi: 10.1016/j.clinthera.2017.09.002. Epub 2017 Sep 22.
2
Family pediatrics: report of the Task Force on the Family.家庭儿科学:家庭问题特别工作组报告
Pediatrics. 2003 Jun;111(6 Pt 2):1541-71.
3
Developing a More Tailored Approach to Patient and Public Involvement with Children and Families in Pediatric Clinical Research: Lessons Learned.制定更具针对性的方法,让儿童和家庭参与儿科临床研究:经验教训。
Ther Innov Regul Sci. 2022 Nov;56(6):948-963. doi: 10.1007/s43441-022-00382-4. Epub 2022 Feb 19.
4
iCAN: Providing a Voice for Children and Families in Pediatric Research.iCAN:为儿童及其家庭在儿科研究中发声。
Ther Innov Regul Sci. 2015 Sep;49(5):673-679. doi: 10.1177/2168479015601344.
5
Role of Patients and Parents in Pediatric Drug Development.患者及家长在儿科药物研发中的作用
Ther Innov Regul Sci. 2019 Sep;53(5):601-608. doi: 10.1177/2168479018820875. Epub 2019 Jan 20.
6
Patient-Centered Research Priorities: A Mixed-Methods Approach from the Colorado Children's Outcomes Network (COCONet).以患者为中心的研究重点:来自科罗拉多儿童结果网络(COCONet)的混合方法研究
J Am Board Fam Med. 2019 Sep-Oct;32(5):674-684. doi: 10.3122/jabfm.2019.05.190028.
7
Putting patient participation into practice in pediatrics-results from a qualitative study in pediatric oncology.将患者参与应用于儿科实践——儿科肿瘤学定性研究的结果
Eur J Pediatr. 2016 Sep;175(9):1147-1155. doi: 10.1007/s00431-016-2754-2. Epub 2016 Aug 1.
8
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.一个就注意力缺陷/多动障碍的诊断和管理达成社区共识的过程。
Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953.
9
Dental screening and referral of young children by pediatric primary care providers.儿科初级保健提供者对幼儿进行牙科筛查和转诊。
Pediatrics. 2004 Nov;114(5):e642-52. doi: 10.1542/peds.2004-1269.
10
Special article: 2014 Pediatric Clinical Trials Forum.特稿:2014年儿科临床试验论坛
Pediatr Res. 2016 Apr;79(4):662-9. doi: 10.1038/pr.2015.255. Epub 2015 Dec 9.

引用本文的文献

1
Attitudes and awareness in autonomous decision on medical treatment or inclusion in clinical trials amongst Slovenian adolescents: an online survey.斯洛文尼亚青少年在医疗自主决策或参与临床试验方面的态度和意识:一项在线调查。
BMC Med Educ. 2024 Oct 23;24(1):1198. doi: 10.1186/s12909-024-06164-w.
2
Co-designing clinical trials alongside youth with chronic pain.与患有慢性疼痛的青少年共同设计临床试验。
Paediatr Neonatal Pain. 2023 May 8;5(4):142-154. doi: 10.1002/pne2.12105. eCollection 2023 Dec.
3
Engaging youth and parents in clinical pediatric research: A case-based example.
让青少年及其父母参与临床儿科研究:一个基于案例的示例。
Paediatr Child Health. 2023 Mar 31;28(4):235-240. doi: 10.1093/pch/pxac111. eCollection 2023 Jul.
4
Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions.利用患者视角为更好的临床试验设计和实施提供信息:当前趋势和未来方向。
Pharmaceut Med. 2023 Mar;37(2):129-138. doi: 10.1007/s40290-022-00458-4. Epub 2023 Jan 18.
5
Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations.儿科肿瘤药物研发的监管格局:专家意见建议
Paediatr Drugs. 2021 Jul;23(4):381-394. doi: 10.1007/s40272-021-00455-1. Epub 2021 Jun 26.
6
Engaging patients and parents to improve mental health intervention for youth with rheumatological disease.让患者和家长参与进来,以改善针对风湿性疾病青少年的心理健康干预。
Pediatr Rheumatol Online J. 2021 Feb 23;19(1):19. doi: 10.1186/s12969-021-00503-7.
7
Facilitators and barriers to the training and maintenance of young persons' advisory groups (YPAGs).青少年咨询小组(YPAGs)培训与维持的促进因素和障碍
Int J Pediatr Adolesc Med. 2020 Dec;7(4):166-173. doi: 10.1016/j.ijpam.2019.10.002. Epub 2019 Nov 8.
8
How to Maximize Children's Involvement in Non-therapeutic Research-Lessons Learnt From EFFECTOR.如何最大化儿童参与非治疗性研究——从EFFECTOR项目中吸取的经验教训
Front Pediatr. 2020 Feb 14;8:47. doi: 10.3389/fped.2020.00047. eCollection 2020.
9
How is the Pharmaceutical Industry Structured to Optimize Pediatric Drug Development? Existing Pediatric Structure Models and Proposed Recommendations for Structural Enhancement.医药行业如何构建以优化儿科药物开发?现有的儿科结构模型和对结构增强的建议。
Ther Innov Regul Sci. 2020 Sep;54(5):1076-1084. doi: 10.1007/s43441-020-00116-4. Epub 2020 Feb 6.
10
Involve Children and Parents in Clinical Studies.让儿童及其家长参与临床研究。
Clin Transl Sci. 2020 Jan;13(1):11-13. doi: 10.1111/cts.12696. Epub 2019 Oct 24.